Artículos del autor

solaci

Antiplatelet

TCT 2021 | STOPDAPT-2 and MASTER-DAPT: The Conversation Continues from ESC to TCT

Research on short-term dual antiplatelet therapy (DAPT) is still controversial. These discussions, however, seem to lead to...
solaci -
Antiplatelet

TCT 2021 | STOPDAPT-2 and MASTER-DAPT: The Conversation Continues from ESC to TCT

Research on short-term dual antiplatelet therapy (DAPT) is still controversial. These discussions, however, seem to lead to...
solaci -
Institutional News

Nov 18 – SOLACI-MEDTRONIC Symposium: Renal Denervation Update

solaci -
Other

TCT 2021 | SWISS-APERO: Difference in Leaks between the Amulet and the Watchman

The Amplatzer Amulet (Abbott) achieves better left atrial appendage closure than the Watchman 2.5 and Watchman FLX...
solaci -
Chronic Ischemic cardiopathy

TCT 2021 | OPTIMUM: Surgically Ineligible Patients with Complex Anatomy: Do We Accept the Case?

In surgically ineligible patients with complex coronary anatomy short term risk of death with PCI is considerably...
solaci -
Institutional News

Nov 13 – Interventional Cardiology Regional Course SOLACI – SOPHIE | Día 2

solaci -
Institutional News

Nov 12 – Interventional Cardiology Regional Course SOLACI – SOPHIE | Day 1

solaci -
Chronic Ischemic cardiopathy

TCT 2021 | FAVOR III: Angiography-Derived FFR: An Event-Prevention Tool

Compared with visual estimation of lesions, using quantitative angiography-derived fractional flow reserve (quantitative flow ration, QFR) provides...
solaci -